eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 39
Letter to the Editor

X-linked reticulate pigmentary disorder in a 4-year-old boy

Yu-Kun Zhao
Li-Hua Fan
Jing-Fa Lu
Ze-Yu Luo
Zhi-Miao Lin
5, 6
Hui-Jun Wang
5, 6, 7
Di-Qing Luo

Department of Dermatology, The East Division of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Zhangzhou Dermatology Hospital, Zhangzhou, Fujian Province, China
Department of Dermatology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi Province, China
Department of Dermatology, Guangzhou Development District Hospital, Guanghzou, China
Peking University First Hospital, Beijing, China
Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China
National Clinical Research Center for Skin and Immune Diseases, Beijing, China
Adv Dermatol Allergol 2022; XXXIX (2): 410-412
Online publish date: 2022/05/09
Article file
- X-linked.pdf  [1.72 MB]
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
A 4-year-old boy from a nonconsanguineous Chinese Han family was referred to the Department of Dermatology, The East Division of The First Affiliated Hospital, Sun Yat-sen University, China, because of dyschromatosis. He was born at full term through an uncomplicated delivery, and developed photophobia as well as bilateral lop ears at the age of 3 months. When he was 6 months old, he developed hypohidrosis that was over the whole body except the neck and outer aspects of the thighs, he also had mild fever of about 37.5°C during the summer or after physical activity, leading to erythema. Hereafter, generalized hyperpigmentation with mottled hypopigmentation developed over his whole body. He had normal growth and normal mental development, and there were no systemic manifestations as well as associations such as pruritus, pain, or burning sensations since his birth. His mother, and grandmother as well as the maternal grandmother on mother's side had multiple, asymptomatic, brownish macules in linear and whorled patterns over the trunk, axillae, groin and extremities after birth, which relieved after adolescence. His elder sister had cleft palate in addition to linear hyperpigmentation. During a 4-year follow-up, the patient’s hypohidrosis and the rise of body temperature had mild improvement although no treatments were ordered, while mottled hypopigmentation increased and was accompanied by more severe hyperpigmentation.
Cutaneous examination showed diffuse reticulate hyperpigmentation with mottled hypopigmentation over the whole body, associated with photophobia, coarse and dried skin, upswept frontal hairline and flared eyebrows (Figures 1 A–C). Skin biopsy was refused.
After informed written consent was obtained from the patient’s parents and other family members, DNA was extracted from peripheral blood of the patient and his family members according to standard methods. Then exome sequencing of the POLA1 gene was performed and revealed hemizygous mutation of NC_000023.10:g.24744696A>G for the patient and heterozygote for his mother and sister (Figures 2 A–C). Then a diagnosis of X-linked reticulate pigmentary disorder was confirmed.
X-linked reticulate pigmentary disorder [XLPDR; MIM301220], first described in a Canadian pedigree [1], is an exceptionally rare genodermatosis inherited as X-linked recessive trait [1–9]. In males, it is always characterized by diffused reticulate dyschromatosis with photophobia, dry skin and typical facial appearance featuring upswept frontal hairline and flared eyebrows. Hypohidrosis is also a distinctive feature, with predilection for trunk and extremities [2, 3] as our patient presented. The systemic manifestations include recurrent infections and autoimmune reactions against various organs including respiratory, gastrointestinal, and neurological systems [2], however, not all patients including the present one had such presentations. The reasons for the absence of systemic manifestations remain unknown which needs further study. Males always have more severe symptoms than female carriers. Whereas the females always present patchy hyperpigmentation along the Blaschko’s lines alone that are similar to stage III incontinentia pigmenti and will alleviate and even disappear after puberty, but without systemic involvements [2, 4, 5], as did in our patient’s mother and his sister. Although cutaneous symptoms and peculiar facial appearance are considered to be the distinctive features of XLPDR [3, 4], absence of skin lesions in infancy had also been reported [4]; in rare instances, the reticulate hyperpigmentation developed until the patient was 8 years old [6]. The absence of skin lesions in early stage may lead to a delayed diagnosis for the patient. Up to date, 25 cases from different families including the present one have been reported [1–9]. However, it is not until 2015 that the mutation of c.1375-354A>G or g.24744696A>G in POLA1 gene was demonstrated as a causal factor for XLPDR [7], and all the patients with genetic demonstration including the present one were detected to have the same intronic mutation in POLA1. Because of the rarity of the disease, it remains to be elucidated whether XLPDR is caused by this mutation specifically, or this mutation stands for one mutation hotspot with additional mutations in POLA1 underlying XLPDR. Nevertheless, it is undoubtedly cost-effective to screen preferentially for this mutation in cases of XLPDR.
The exact mechanisms for XLPDR as well as POLA1 remain fully unknown. POLA1 protein, or DNA polymerase alpha catalytic subunit, is necessary for initiation of DNA replication and the synthesis of cytosolic RNA:DNA, which directly modulates interferon-regulatory factors [3, 7]. The reduction of POLA1 expression may result in diminished cytosolic RNA:DNA hybrids [3, 7], which are responsible for the negative regulation of interferon-regulatory factors, leading to increase of type I interferon [3, 7]. It has been reported recently that XLPDR was associated with a decreased number and selective cytotoxicity defect of NK cells [3]; this might be why the patients have autoinflammation and recurrent infection [6, 7]. Interestingly, no recurrent cutaneous infection has been described up to date. The histopathological features of XLPDR are similar in both sexes, including mild hyperkeratosis, acanthosis, basal hyperpigmentation, and pigmentary incontinence in the upper dermis [2, 4, 6]. Deposition of amyloid-like material in the papillary dermis and mild superficial lymphocytic perivascular infiltrate may also be present [2, 4, 6]. Direct immunofluorescence may reveal granular deposits of C3 at the dermoepidermal junction [6]. However, these histopathological findings are non-specific for the disease [2, 4]. The mechanisms for pigmentation also remain elusive. Accumulation of melanophages and amyloid-like materials had been found in the upper dermis [1, 2, 4, 5, 6], suggesting that those might be responsible for the hyperpigmentation. Of course, further studies are still required to verify this speculation and clarify the function of POLA1 in skin.
Differential diagnosis of XLPDR includes incontinentia pigmenti, primary cutaneous amyloidosis, Rothmund-Thomson syndrome, Kindler syndrome, congenital dyskeratosis, and Naegeli–Franceschetti syndrome [1, 4, 5, 8]. Based on the featuring presentations and inherited trait, it is not hard to make a correct diagnosis, sometimes, sequencing of the POLA1 gene is an optimal option. No therapeutics are recommended for the disease at present yet.


The authors sincerely thank the patient and his family members participating the present work. Yu-Kun Zhao, Li-Hua Fan and Jing-Fa Lu contributed equally for the present work.

Conflict of interest

The authors declare no conflict of interest.


1. Partington MW, Marriott PJ, Prentice RS, et al. Familial cutaneous amyloidosis with systemic manifestations in males. Am J Med Genet 1981; 10: 65-75.
2. Kim BS, Seo SH, Jung HD, et al. X-Linked reticulate pigmentary disorder in a female patient. Int J Dermatol 2010; 49: 421-5.
3. Starokadomskyy P, Wilton KM, Krzewski K, et al. NK cell defects in X-linked pigmentary reticulate disorder. JCI Insight 2019; 4: e125688.
4. Pezzani L, Brena M, Callea M, et al. X-linked reticulate pigmentary disorder with systemic manifestations: a new family and review of the literature. Am J Med Genet A 2013; 161A: 1414-20.
5. Anderson RC, Zinn AR, Kim J, Carder KR. X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review. Pediatr Dermatol 2005; 22: 122-6.
6. Starokadomskyy P, Sifuentes-Dominguez L, Gemelli T, et al. Evolution of the skin manifestations of X-linked pigmentary reticulate disorder. Br J Dermatol 2017; 177: e200-1.
7. Starokadomskyy P, Gemelli T, Rios JJ, et al. DNA polymerase-alpha regulates the activation of type I interferons through cytosolic RNA:DNA synthesis. Nat Immunol 2016; 17: 495-504.
8. Ades LC, Rogers M, Sillence DO. An X-linked reticulate pigmentary disorder with systemic manifestations: report of a second family. Pediatr Dermatol 1993; 10: 344-51.
9. Fraile G, Norman F, Reguero ME, et al. Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) in a man with a diagnosis of X-linked reticulate pigmentary disorder (PDR). Scand J Gastroenterol 2008; 43: 506-10.
Copyright: © 2022 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.